Page last updated: 2024-09-04

arginine beta-naphthylamide and 1,2,6-tri-o-galloyl-beta-d-glucopyranose

arginine beta-naphthylamide has been researched along with 1,2,6-tri-o-galloyl-beta-d-glucopyranose in 1 studies

Compound Research Comparison

Studies
(arginine beta-naphthylamide)
Trials
(arginine beta-naphthylamide)
Recent Studies (post-2010)
(arginine beta-naphthylamide)
Studies
(1,2,6-tri-o-galloyl-beta-d-glucopyranose)
Trials
(1,2,6-tri-o-galloyl-beta-d-glucopyranose)
Recent Studies (post-2010) (1,2,6-tri-o-galloyl-beta-d-glucopyranose)
23091106

Protein Interaction Comparison

ProteinTaxonomyarginine beta-naphthylamide (IC50)1,2,6-tri-o-galloyl-beta-d-glucopyranose (IC50)
Genome polyprotein 1.89
Squalene monooxygenase Rattus norvegicus (Norway rat)0.63

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bag, A; Chattopadhyay, RR1

Other Studies

1 other study(ies) available for arginine beta-naphthylamide and 1,2,6-tri-o-galloyl-beta-d-glucopyranose

ArticleYear
Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli.
    Natural product research, 2014, Volume: 28, Issue:16

    Topics: Anti-Bacterial Agents; Arginine; Dipeptides; Drug Resistance, Multiple, Bacterial; Fruit; Hydrolyzable Tannins; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Structure; Terminalia; Uropathogenic Escherichia coli

2014